KRAS and cancer: KRAS is one of the most frequently mutated oncogenes in cancer: Approximately 30 to 40% of patients with colorectal cancer harbor missense mutations in KRAS, and KRAS mutations have long been associated with increased tumor aggressiveness, resistance to treatment, and poor patient outcomes (42).